Want to join the conversation?
$PRGO said its financial results were below internal expectations. The company missed its internal EPS expectation in 2Q16 primarily as a result of the pricing impact in the Rx segment. $PRGO added it continues to build out the acquired products in the weight loss and smoking cessation categories across the platform, which is performing well.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.